Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Lixte Biotech Hlds (LIXT)

Lixte Biotech Hlds (LIXT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Lixte Biotech Hlds 680 EAST COLORADO BOULEVARD SUITE 180 PASADENA CA 91101 USA

P: 631-830-7092 F: 631-982-5050

Description:

Lixte Biotechnology Holdings Inc. is a drug discovery company which uses biomarker technology to identify enzyme targets associated with serious common diseases. The company's product pipeline is primarily focused on inhibitors of protein phosphatases, used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers. Lixte Biotechnology Holdings Inc. is based in NY.

Key Statistics

Overview:

Market Capitalization, $K 20,975
Enterprise Value, $K 19,655
Shares Outstanding, K 16,647
Annual Sales, $ 0 K
Annual Net Income, $ -6,730 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,478 K
60-Month Beta -0.26
% of Insider Shareholders 29.20%
% of Institutional Shareholders 3.90%
Float, K 11,786
% Float 70.80%
Short Volume Ratio 0.37

Growth:

1-Year Return -32.98%
3-Year Return -72.73%
5-Year Return 28.05%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.09 on 11/08/22
Next Earnings Date 03/20/23
Earnings Per Share ttm -0.31
EPS Growth vs. Prev Qtr 10.00%
EPS Growth vs. Prev Year 0.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-6 on 11/20/20

LIXT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -328.68%
Return-on-Assets % -111.58%
Profit Margin % 0.00
Net Margin % N/A
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 4.64
Book Value/Share 0.00
Interest Coverage -672.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar